Comparative Pharmacology
Head-to-head clinical analysis: ADIPEX P versus PLEGINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ADIPEX P versus PLEGINE.
ADIPEX-P vs PLEGINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Phentermine is a sympathomimetic amine that stimulates release of norepinephrine and to a lesser extent dopamine and serotonin from presynaptic nerve terminals in the hypothalamic feeding center, resulting in appetite suppression.
Plegine (phendimetrazine) is a sympathomimetic amine that acts as an anorectic agent. It stimulates the hypothalamus to release norepinephrine and dopamine, thereby suppressing appetite. The exact mechanism is thought to involve the release of catecholamines from presynaptic nerve terminals in the lateral hypothalamic feeding center, leading to decreased food intake.
Phentermine (ADIPEX-P) is typically dosed as 15–37.5 mg orally once daily, administered 2 hours after breakfast or before breakfast. The 37.5 mg tablet is taken once daily before breakfast or 1–2 hours after breakfast; some patients may require 15 mg or 30 mg (half of a 37.5 mg tablet) once daily. The extended-release formulation (ADIPEX-P) is not available; only immediate-release tablets are marketed. Duration of therapy should be limited to a few weeks (e.g., 4–12 weeks) due to potential for tolerance and abuse.
25-50 mg orally once daily at bedtime, maximum 100 mg/day.
None Documented
None Documented
Terminal half-life approximately 20-25 hours. Clinical context: Steady-state reached within 4-5 days; dosing adjustments may be needed in renal impairment.
Terminal elimination half-life: 4–8 hours (mean 6 hours). Clinical context: Steady-state achieved after 24–48 hours of repeated dosing.
Primarily renal (70-90% unchanged); minor biliary/fecal (10-30% as metabolites). Urinary pH-dependent; acidic urine increases excretion.
Renal: 40% unchanged; Hepatic metabolism: 60% (biliary/fecal elimination of metabolites).
Category C
Category C
Anorexiant
Anorexiant